Endothelial to haematopoietic transition contributes to pulmonary arterial hypertension. Issue 13 (7th September 2017)

• Record Type: Journal Article
• Authors: Liang, Olin D.; So, Eui-Young; Egan, Pamela C.; Goldberg, Laura R.; Aliotta, Jason M.; Wu, Keith Q.; Dubielecka, Patrycja M.; Ventetuolo, Corey E.; Reginato, Anthony M.; Quesenberry, Peter J.; Klinger, James R.
• Is Part Of: Cardiovascular research. Volume 113:Issue 13(2017)
• Page Start: 1560
• Page End: 1573
• Publication Date: 2017-09-07
• Subjects: Endothelial to haematopoietic transition -- Endothelial progenitor cells -- Transcription factor Runx1 -- Haematopoiesis -- Pulmonary arterial hypertension; Cardiovascular system -- Diseases -- Periodicals; Cardiovascular system -- Periodicals; 616.1
• DOI: 10.1093/cvr/cvx161
• Languages: English
• ISSNs: 0008-6363

Abstract

Abstract: Aims: The pathogenic mechanisms of pulmonary arterial hypertension (PAH) remain unclear, but involve dysfunctional endothelial cells (ECs), dysregulated immunity and inflammation in the lung. We hypothesize that a developmental process called endothelial to haematopoietic transition (EHT) contributes to the pathogenesis of pulmonary hypertension (PH). We sought to determine the role of EHT in mouse models of PH, to characterize specific cell types involved in this process, and to identify potential therapeutic targets to prevent disease progression. Methods and results: When transgenic mice with fluorescence protein ZsGreen-labelled ECs were treated with Sugen/hypoxia (Su/Hx) combination to induce PH, the percentage of ZsGreen+ haematopoietic cells in the peripheral blood, primarily of myeloid lineage, significantly increased. This occurrence coincided with the depletion of bone marrow (BM) ZsGreen+ c-kit+ CD45− endothelial progenitor cells (EPCs), which could be detected accumulating in the lung upon PH-induction. Quantitative RT-PCR based gene array analysis showed that key transcription factors driving haematopoiesis were expressed in these EPCs. When transplanted into lethally irradiated recipient mice, the BM-derived EPCs exhibited long-term engraftment and haematopoietic differentiation capability, indicating these EPCs are haemogenic in nature. Specific inhibition of the critical haematopoietic transcription factor Runx1 blocked the EHT process in vivo, prevented egress of the BM EPCs and ultimately attenuated PH progression in Su/Hx- as well as in monocrotaline-induced PH in mice. Thus, myeloid-skewed EHT promotes the development of PH and inhibition of this process prevents disease progression in mouse models of PH. Furthermore, high levels of Runx1 expression were found in circulating CD34+ CD133+ EPCs isolated from peripheral blood of patients with PH, supporting the clinical relevance of our proposed mechanism of EHT. Conclusion: EHT contributes to the pathogenesis of PAH. The transcription factor Runx1 may be a novel therapeutic target for the treatment of PAH.